Evéquoz D, Waeber B, Matsueda G, Nussberger J, Brunner H R
Division of Hypertension, Centre Hospitalier Universitaire, Lausanne, Switzerland.
Eur J Pharmacol. 1987 Dec 1;144(2):217-21. doi: 10.1016/0014-2999(87)90522-x.
This study was undertaken to test whether the presence or absence of a functioning adrenal medulla influences the blood pressure response of conscious normotensive rats to a 30 min infusion of vasodilating agents such as atriopeptin III (1 microgram/min i.v.), a synthetic atrial natriuretic peptide, and sodium nitroprusside (8 micrograms/min i.v.). Rats either had their adrenal medulla removed or were sham-operated 8-10 days before the experimental day. The blood pressure lowering effect of sodium nitroprusside, but not that of atriopeptin III, was enhanced in rats with no adrenal medulla.
本研究旨在测试肾上腺髓质功能的有无是否会影响清醒正常血压大鼠对血管舒张剂(如心房肽III(静脉注射1微克/分钟),一种合成的心房利钠肽,和硝普钠(静脉注射8微克/分钟))30分钟输注的血压反应。在实验日前8 - 10天,大鼠要么接受肾上腺髓质切除,要么接受假手术。无肾上腺髓质的大鼠中,硝普钠的降压作用增强,但心房肽III的降压作用未增强。